SMALL CELL CARCINOMA OF THE BLADDER
Clinical trials for SMALL CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: drug combo trial launches
Disease control Recruiting nowThis phase 2 trial tests whether the drug sacituzumab govitecan, alone or combined with atezolizumab, can shrink rare tumors of the kidney, bladder, ureters, or penis. About 60 adults with specific rare cancer types will receive the drugs intravenously in 21-day cycles. The study…
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo targets rare bladder cancer
Disease control Recruiting nowThis phase II trial tests two drugs, lurbinectedin and avelumab, in people with a rare and aggressive bladder cancer called small cell carcinoma. Participants who have already had a drug like avelumab will receive only lurbinectedin; others will get both. The study aims to see if…
Matched conditions: SMALL CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC